Bristol-Myers SquibbBristol-Myers Squibb / Photograph: Rept0n1x by way of Wikimedia Co

Kirkland & Ellis, nonetheless among the many league table leaders in deal worth and quantity amidst a down 12 months for M&A and for the agency’s observe in that space, received a pleasant shot within the arm to begin This fall because the agency represented Bristol Myers Squibb (BMS) in its $13.1 billion acquisition of fellow pharmaceutical firm MyoKardia on Monday. The latter was represented by Goodwin Procter.